Amol Ugale

Amol Ugale

Auto-generated profile, based on publicly available information

Amol Ugale

Max Perutz Labs Vienna, University of Vienna, Immunobiology and Genetics 1 Department of Microbiology Vienna, Austria

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 June 2024 in Journal of Cell Biology
Verified
Journal Article
Open access
AUAmol Ugale
Amol Ugale
DSDhanlakshmi Shunmugam
Dhanlakshmi Shunmugam
LPLokesh G. Pimpale
Lokesh G. Pimpale
ERElisabeth Rebhan
Elisabeth Rebhan
MBManuela Baccarini
Manuela Baccarini
Hematopoietic stem cells (HSCs) continuously replenish mature blood cells with limited lifespans. To maintain the HSC compartment while ensuring output of differentiated cells, HSCs undergo asymmetric cell division (ACD), generating two daughter cells with different fates: one will proliferate and give rise to the differentiated cells’ progeny, and one will return to quiescence to maintain the HSC compartment. A balance between MEK/ERK and mTORC1 pathways is needed to ensure HSC homeostasis. Here, we show that activation of these pathways is spatially segregated in premitotic HSCs and unequally inherited during ACD. A combination of genetic and chemical perturbations shows that an ERK-dependent mechanism determines the balance between pathways affecting polarity, proliferation, and metabolism, and thus determines the frequency of asymmetrically dividing HSCs. Our data identify druggable targets that modulate HSC fate determination at the level of asymmetric division.